Capricor’s Duchenne treatment fails to get FDA approval, shares sink

Regulatory Approvals — Capricor's Duchenne treatment fails to get FDA approval, shares sink  Reuters

Read the original at Regulatory Approvals ↗

Auto-published by the finit.news Events monitor from Regulatory Approvals; summarized by AI and may contain errors — verify against the primary source. November 21, 2026.

By